Ionetix grants stock options to executives and directors, adopts bonus plan
On October 23, 2026, Ionetix Corporation's Compensation Committee granted stock options to its CEO and CFO, adopted a non-employee director compensation plan, and approved an annual bonus plan for its subsidiary.
On October 23, 2026, the Compensation Committee of Ionetix Corporation's board of directors granted stock option awards under the Company's 2026 Equity Incentive Plan, including a stock option to purchase 1,025,600 shares to Kevin Cameron, the Company's President and Chief Executive Officer, and a stock option to purchase 854,700 shares to Phieu Phun, the Company's Chief Financial Officer.1
Each option has an exercise price of $3.00 per share, determined by the Board to be the fair market value on the grant date, and vests as to 25% on the first anniversary of the grant date with the remainder vesting monthly over 36 months, expiring 10 years from the grant date.1 The options are also subject to employment agreements between Ionetix Radioisotopes, Inc., formerly known as Ionetix Corporation and now the Company's wholly owned subsidiary, and each named executive officer dated April 1, 2026, which provide for full vesting acceleration upon an Involuntary Separation.1
The Board also adopted a Non-Employee Director Compensation Plan the same day. The plan does not presently provide for cash retainers but provides equity awards under the 2026 Equity Plan, including initial awards for new directors and annual awards for continuing directors.1 Under this plan, the Board approved an initial award to Michael Stewart of a stock option to purchase 175,000 shares, and annual awards to Gregory Martin, Douglas Boothe, and Michael Tarnok, each consisting of options to purchase 100,000 shares and 15,000 restricted stock units.1 These options also carry a $3.00 exercise price.1
Separately, the board of Ionetix Radioisotopes adopted an Annual Performance Bonus Plan effective for the 2026 calendar year, providing eligible full-time employees with discretionary annual cash bonuses based on target percentages of base salary and performance against corporate and individual goals.1 Radioisotopes' CEO and CFO are not eligible to participate in the Bonus Plan.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.